Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Treatment.com International ( (TSE:TRUE) ) has provided an update.
Treatment.com AI Inc. has announced that its subsidiary, Rocket Doctor, has partnered with a California managed care plan to provide healthcare services to approximately 450,000 Medicaid members. This partnership is expected to enhance healthcare access by offering tele-urgent care, specialty services, and primary care through a virtual care platform, reducing unnecessary emergency room visits and wait times, while generating an anticipated additional annual recurring revenue of approximately US$1.2 million.
More about Treatment.com International
YTD Price Performance: 23.64%
Average Trading Volume: 7,739
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $20.37M
Find detailed analytics on TRUE stock on TipRanks’ Stock Analysis page.